Advaxis (ADXS) Approved for $2.7M NJEDA NOL Program Tax Credit

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. WCN
7. SPOT
8. SPY
9. FIX
10. NDAQ

Go back to Advaxis (ADXS) Approved for $2.7M NJEDA NOL Program Tax Credit

Advaxis to Receive $2.5M through the New Jersey Economic Development Authority NOL Program

October 13, 2016 8:00 AM EDT

PRINCETON, N.J., Oct. 13, 2016 (GLOBE NEWSWIRE) -- Advaxis, Inc. (NASDAQ: ADXS), a clinical stage biotechnology company developing cancer immunotherapies, has received preliminary approval for a $2.7 million tax credit from the New Jersey Economic Development Authoritys (NJEDA) New Jersey Technology Business Tax Certificate Transfer (NOL) program. The company anticipates it will be able to transfer this credit and receive... More